No takes yet. Share an insight, caveat, or question.
Narrative review demonstrates potent lipid lowering and minimal cytochrome P450 metabolism with pitavastatin, indicating reduced adverse drug interactions in dyslipidemia management.
Hayashi et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: